Skip to main content

Table 3 Survival outcomes in association with telomerase expression and telomere length in all patients

From: Telomerase expression and telomere length in breast cancer and their associations with adjuvant treatment and disease outcome

Variable Overall Survival Disease-free Survival
  HR (95% CI)* AHR (95% CI)** HR (95% CI)* AHR (95% CI)**
Telomerase     
Low telomerase 1.00 1.00 1.00 1.00
High telomerase 1.46 (0.87 to 2.45) 1.31 (0.78 to 2.22) 1.25 (0.80 to 1.95) 1.21 (0.79 to 1.94)
Telomere length     
Short telomere 1.00 1.00 1.00 1.00
Long telomere 0.79 (0.47 to 1.31) 0.83 (0.49 to 1.40) 0.84 (0.55 to 1.31) 0.83 (0.53 to 1.31)
  1. *HR, hazard ratio; 95% CI, 95% confidence interval.
  2. ** AHR, adjusted hazard ratio; adjusted for patient age at surgery, disease stage, tumor grade, histological type, estrogen- and progesterone-receptor status.